Suicide and Trauma in Persons living with HIV

  • STATUS
    Enrolling By Invitation
Updated on 19 February 2024

Summary

Rates of posttraumatic stress disorder (PTSD), substance use, sleep disorders and suicide are disproportionately higher in persons living with HIV (PLWH). The Syndemic Model of Substance Abuse, Intimate Partner Violence, and HIV (SAVA Syndemic), refers to the frequent co-occurrence and mutual influence between these conditions. The SAVA Syndemic has not been directly associated with suicide risk. The pathway to developing suicidal ideation and to transitioning from thinking about suicide to engaging in suicidal behaviors in PLWH is unclear. An analysis of demographic and clinical variables associated with increased risk for suicide in PLWH is essential to formulate testable hypotheses and elucidate pathways to suicide within the context of the SAVA Syndemic. We have identified the following specific aims: Aim 1: To determine variables associated with the presence of suicidal ideation in PLWH. Aim 2: To determine variables associated with the emergence of suicidal ideation. Aim 3: To variables associated with the transition from suicidal ideation to suicidal behavior in PLWH. In Phase I, we will conduct a comprehensive chart review of PLWH within the CFAR longitudinal database and link this database with medical records to determine the associations among PTSD, substance use, sleep disorders, and suicide risk. We will repeat these analyses with the larger electronic medical record system using a de-identified database of all HIV+ individuals, generated in collaboration with the Clinical Research Computing Unit (CRCU) at Penn. In Phase II, we will follow a small sample (n = 10-20) of participants who have HIV for one month. We will use ecological momentary assessment, FitBit®, and sleep diaries to inform the associations among PTSD, substance use, sleep disorders, and suicide risk.

Details
Condition HIV, suicide
Age 99years or below
Clinical Study IdentifierTBD
Last Modified on19 February 2024

Eligibility

If you need help finding a study or have any questions, please contact us at psom-ocr@pobox.upenn.edu

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.